View Item 

Show simple item record

Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis
dc.contributor.authorOhara, Ray A.
dc.contributor.authorEdhayan, Gautam
dc.contributor.authorRasmussen, Stephanie M.
dc.contributor.authorIsozaki, Takeo
dc.contributor.authorRemmer, Henriette A.
dc.contributor.authorLanigan, Thomas M.
dc.contributor.authorCampbell, Phillip L.
dc.contributor.authorUrquhart, Andrew G.
dc.contributor.authorLawton, Jeffrey N.
dc.contributor.authorChung, Kevin C.
dc.contributor.authorFox, David A.
dc.contributor.authorRuth, Jeffrey H.
dc.date.accessioned2019-08-09T17:13:34Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2019-08-09T17:13:34Z
dc.date.issued2019-08
dc.identifier.citationOhara, Ray A.; Edhayan, Gautam; Rasmussen, Stephanie M.; Isozaki, Takeo; Remmer, Henriette A.; Lanigan, Thomas M.; Campbell, Phillip L.; Urquhart, Andrew G.; Lawton, Jeffrey N.; Chung, Kevin C.; Fox, David A.; Ruth, Jeffrey H. (2019). "Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis." Arthritis & Rheumatology 71(8): 1241-1251.
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/2027.42/150530
dc.publisherWiley Periodicals, Inc.
dc.titleCitrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelRheumatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/150530/1/art40886_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/150530/2/art40886.pdf
dc.identifier.doi10.1002/art.40886
dc.identifier.sourceArthritis & Rheumatology
dc.identifier.citedreferencePratesi F, Dioni I, Tommasi C, Alcaro MC, Paolini I, Barbetti F, et al. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann Rheum Dis 2014; 73: 1414 – 22.
dc.identifier.citedreferenceIsozaki T, Amin MA, Arbab AS, Koch AE, Ha CM, Edhayan G, et al. Inhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritis. Arthritis Res Ther 2014; 16: R68.
dc.identifier.citedreferenceEdhayan G, Ohara RA, Stinson WA, Amin MA, Isozaki T, Ha CM, et al. Inflammatory properties of inhibitor of DNA binding 1 secreted by synovial fibroblasts in rheumatoid arthritis. Arthritis Res Ther 2016; 18: 87.
dc.identifier.citedreferenceMor‐Vaknin N, Punturieri A, Sitwala K, Faulkner N, Legendre M, Khodadoust MS, et al. The DEK nuclear autoantigen is a secreted chemotactic factor. Mol Cell Biol 2006; 26: 9484 – 96.
dc.identifier.citedreferenceMor‐Vaknin N, Kappes F, Dick AE, Legendre M, Damoc C, Teitz‐Tennenbaum S, et al. DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen. Arthritis Rheum 2011; 63: 556 – 67.
dc.identifier.citedreferenceArnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315 – 24.
dc.identifier.citedreferenceBrinkman EK, Chen T, Amendola M, van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res 2014; 42: e168.
dc.identifier.citedreferenceYoshida K, Korchynskyi O, Tak PP, Isozaki T, Ruth JH, Campbell PL, et al. Citrullination of epithelial neutrophil–activating peptide 78/CXCL5 results in conversion from a non–monocyte‐recruiting chemokine to a monocyte‐recruiting chemokine. Arthritis Rheumatol 2014; 66: 2716 – 27.
dc.identifier.citedreferencePrevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty‐eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44 – 8.
dc.identifier.citedreferenceAletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23 Suppl 39: S100 – 8.
dc.identifier.citedreferenceHao G, Wang D, Gu J, Shen Q, Gross SS, Wang Y. Neutral loss of isocyanic acid in peptide CID spectra: a novel diagnostic marker for mass spectrometric identification of protein citrullination. J Am Soc Mass Spectrom 2009; 20: 723 – 7.
dc.identifier.citedreferenceHan Z, Boyle DL, Shi Y, Green DR, Firestein GS. Dominant‐negative p53 mutations in rheumatoid arthritis. Arthritis Rheum 1999; 42: 1088 – 92.
dc.identifier.citedreferenceBartok B, Firestein GS. Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010; 233: 233 – 55.
dc.identifier.citedreferenceNishimoto N, Ito A, Ono M, Tagoh H, Matsumoto T, Tomita T, et al. IL‐6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL‐6 receptor. Int Immunol 2000; 12: 187 – 93.
dc.identifier.citedreferenceHara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, et al. Id‐related genes encoding helix‐loop‐helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 1994; 269: 2139 – 45.
dc.identifier.citedreferenceClavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, Sebbag M, et al. Induction of macrophage secretion of tumor necrosis factor α through Fcγ receptor IIa engagement by rheumatoid arthritis‐specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 2008; 58: 678 – 88.
dc.identifier.citedreferenceSokolove J, Zhao X, Chandra PE, Robinson WH. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll‐like receptor 4 and Fcgγ receptor. Arthritis Rheum 2011; 63: 53 – 62.
dc.identifier.citedreferenceWigerblad G, Bas DB, Fernades‐Cerqueira C, Krishnamurthy A, Nandakumar KS, Rogoz K, et al. Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine‐dependent mechanism. Ann Rheum Dis 2016; 75: 730 – 8.
dc.identifier.citedreferenceHabets KL, Trouw LA, Levarht EW, Korporaal SJ, Habets PA, de Groot P, et al. Anti‐citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis. Arthritis Res Ther 2015; 17: 209.
dc.identifier.citedreferenceKlareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38 – 46.
dc.identifier.citedreferenceHarre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012; 122: 1791 – 802.
dc.identifier.citedreferenceEngdahl C, Bang H, Dietel K, Lang SC, Harre U, Schett G. Periarticular bone loss in arthritis is induced by autoantibodies against citrullinated vimentin. J Bone Miner Res 2017; 32: 1681 – 91.
dc.identifier.citedreferenceProost P, Loos T, Mortier A, Schutyser E, Gouwy M, Noppen S, et al. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J Exp Med 2008; 205: 2085 – 97.
dc.identifier.citedreferenceStruyf S, Noppen S, Loos T, Mortier A, Gouwy M, Verbeke H, et al. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti‐HIV‐1 activity via CXCR4. J Immunol 2009; 182: 666 – 74.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
art40886_am.pdf
Size:
286.8KB
Format:
PDF
View/Open
Name:
art40886.pdf
Size:
881.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.